{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:32Z","timestamp":1792787792819,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":76,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"South London and Maudsley NHS Foundation Trust & Institute of Psychiatry NIHR Biomedical Research Centre for Mental Health","id":[{"id":"https:\/\/ror.org\/015803449","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust","id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.psyneuen.2012.12.025","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T13:49:31Z","timestamp":1359380971000},"page":"603-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["A systematic review of the activity of the hypothalamic\u2013pituitary\u2013adrenal axis in first episode psychosis"],"prefix":"10.1016","volume":"38","author":[{"given":"Susana","family":"Borges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Gayer-Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2012.12.025_bib0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/S0033291710001170","article-title":"Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis","volume":"41","author":"Aas","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1192\/bjp.168.1.57","article-title":"Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients","volume":"168","author":"Abel","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0015","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.psyneuen.2012.05.003","article-title":"Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with \u201cat risk\u201d mental state","volume":"37","author":"Aiello","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-1781(92)90070-J","article-title":"In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients","volume":"44","author":"Axelson","year":"1992","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.psyneuen.2011.08.013","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis and clinical symptoms in first-episode psychosis","volume":"37","author":"Belvederi","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0030","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1176\/appi.ajp.160.10.1890","article-title":"Increase in concentration of waking salivary cortisol in recovered patients with depression","volume":"160","author":"Bhagwagar","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0035","first-page":"1","article-title":"Increased salivary cortisol after waking in depression","author":"Bhagwagar","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.schres.2007.11.009","article-title":"Effects of acute metabolic stress on the dopaminergic and pituitary adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls","volume":"100","author":"Brunelin","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2010.09.022","article-title":"Pituitary volume increase during emerging psychosis","volume":"125","author":"Buschlen","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.euroneuro.2008.10.006","article-title":"Psychosis and brain volume changes during the first five years of schizophrenia","volume":"19","author":"Cahn","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0055","first-page":"433","article-title":"Dexamethasone suppression test in first-episode schizophrenia","volume":"27","author":"Ceskova","year":"2006","journal-title":"Neuro. Endocrinol. Lett."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/er.2002-0014","article-title":"The neuroendocrinology of chronic fatigue syndrome","volume":"24","author":"Cleare","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00213-005-0279-x","article-title":"The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects","volume":"185","author":"Cohrs","year":"2006","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.psyneuen.2012.12.025_bib0070","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1017\/S0033291711000602","article-title":"Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis","volume":"41","author":"Collip","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.schres.2011.11.035","article-title":"HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia","volume":"135","author":"Corcoran","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2011.07.025","article-title":"Prolactin concentrations in newly diagnosed, antipsychotic-na\u00efve patients with non-affective psychosis","volume":"134","author":"Garcia-Rizo","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.schres.2009.05.008","article-title":"Pituitary volume and early treatment response in drug-naive first-episode psychosis patients","volume":"113","author":"Garner","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biopsych.2005.04.018","article-title":"Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis","volume":"58","author":"Garner","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpsychires.2010.06.008","article-title":"Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis","volume":"45","author":"Garner","year":"2011","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.psyneuen.2012.12.025_bib0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pscychresns.2011.09.017","article-title":"Pituitary volume in first-episode schizophrenia","volume":"203","author":"Gruner","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.schres.2007.03.025","article-title":"Cortisol levels in relation to hippocampal sub-regions in subjects with first episode schizophrenia","volume":"94","author":"Gunduz-Bruce","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0110","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1017\/S0033291711002728","article-title":"Pituitary volume, stress reactivity and genetic risk for psychotic disorder","volume":"42","author":"Habets","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.psyneuen.2008.10.026","article-title":"Salivary cortisol as a biomarker in stress research","volume":"34","author":"Hellhammer","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1440-1819.2010.02121.x","article-title":"Diurnal cortisol patterns of young male patients with schizophrenia","volume":"64","author":"Hempel","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1176\/ajp.142.1.127","article-title":"The dexamethasone suppression test in newly hospitalized schizophrenic patients","volume":"142","author":"Herz","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000322146","article-title":"Schizotypal personality in healthy adults is related to blunted cortisol responses to the combined dexamethasone\/corticotropin-releasing hormone test","volume":"63","author":"Hori","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pnpbp.2006.10.007","article-title":"The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study","volume":"31","author":"Jakoveljevic","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.psychres.2009.01.013","article-title":"Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism","volume":"175","author":"Kale","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0306-4530(94)90013-2","article-title":"Salivary cortisol in psychoneuroendocrine research: recent developments and applications","volume":"19","author":"Kirschbaum","year":"1994","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1461145711000794","article-title":"Hypothalamus and pituitary volume in schizophrenia: a structural MRI study","volume":"15","author":"Klomp","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0155","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0006-3223(95)00065-8","article-title":"Combined dexamethasone\/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II","volume":"38","author":"Lammers","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0160","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.schres.2007.01.022","article-title":"Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study","volume":"92","author":"MacMaster","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0006-8993(00)02950-4","article-title":"The neurobiology of stress: from serendipity to clinical relevance","volume":"886","author":"McEwen","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0170","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1037\/h0026836","article-title":"Current methodology in research on the etiology of schizophrenia: serious difficulties which suggest the use of high-risk-group method","volume":"70","author":"Mednick","year":"1968","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.schres.2003.10.008","article-title":"Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder","volume":"70","author":"Mitropolou","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2011.02.022","article-title":"Minor physical anomalies and vulnerability in prodromal youth","volume":"129","author":"Mittal","year":"2011","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.psyneuen.2012.12.025_bib0185","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.biopsych.2006.08.043","article-title":"The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol","volume":"61","author":"Mittal","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0190","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.4088\/JCP.10m06745","article-title":"Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume","volume":"72","author":"Mondelli","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0195","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.psyneuen.2008.05.010","article-title":"Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder","volume":"33","author":"Mondelli","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.schres.2009.08.013","article-title":"Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment","volume":"116","author":"Mondelli","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.schres.2009.12.021","article-title":"Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis","volume":"119","author":"Mondelli","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cpr.2006.09.005","article-title":"Stress-reactivity in psychosis: evidence for an affective pathway to psychosis","volume":"27","author":"Myin-Germeys","year":"2007","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.schres.2009.10.005","article-title":"The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study","volume":"116","author":"Nicolo","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0220","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/sj.npp.1300766","article-title":"Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study","volume":"30","author":"Pariante","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0269881107084020","article-title":"Pituitary volume in psychosis: the first review of the evidence","volume":"22","author":"Pariante","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0230","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.185.1.5","article-title":"Pituitary volume in psychosis","volume":"185","author":"Pariante","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0240","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000103868","article-title":"Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia","volume":"85","author":"Popovic","year":"2007","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0245","article-title":"Blunted cortisol awakening response in men with first episode psychosis: relationship to parental bonding","author":"Pruessner","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0250","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1176\/appi.ajp.160.9.1554","article-title":"When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders","volume":"160","author":"Raison","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1192\/bjp.184.2.136","article-title":"Salivary cortisol response to awakening in chronic fatigue syndrome","volume":"184","author":"Roberts","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopsycho.2006.09.002","article-title":"The effects of social stress and cortisol responses on the preconscious selective attention to social threat","volume":"75","author":"Roelofs","year":"2007","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0265","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2003.11.018","article-title":"Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder","volume":"55","author":"Rohleder","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0270","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0275","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.lfs.2003.08.044","article-title":"The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia","volume":"74","author":"Ryan","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0280","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.psyneuen.2003.08.011","article-title":"Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia","volume":"29","author":"Ryan","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0285","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/ajp.126.8.1067","article-title":"Psychoendocrinology of ego disintegration","volume":"126","author":"Sachar","year":"1970","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0290","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0295","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.schres.2004.03.005","article-title":"Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology","volume":"71","author":"Strous","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0300","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archgenpsychiatry.2009.12","article-title":"Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis","volume":"66","author":"Takahashi","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pnpbp.2010.10.023","article-title":"Longitudinal volume changes of the pituitary gland in patients with schizotypal disorder and first-episode schizophrenia","volume":"35","author":"Takahashi","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0310","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.pnpbp.2008.05.013","article-title":"Decreased levels of ghrelin, cortisol, and fasting blood sugar, but not n-octanoylated ghrelin, in Japanese schizophrenic inpatients treated with olanzapine","volume":"32","author":"Tanaka","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0315","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0006-3223(91)90353-N","article-title":"Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome","volume":"29","author":"Tandon","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0320","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.schres.2006.09.033","article-title":"Pituitary volume in neuroleptic-na\u00efve schizophrenia: a structural MRI study","volume":"90","author":"Upadhyaya","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0325","article-title":"Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis","author":"van Venrooij","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0330","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S0033291711001826","article-title":"Dissociation mediates the relationship between childhood trauma and hallucination-proneness","volume":"42","author":"Varese","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0335","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.clinpsy.4.022007.141248","article-title":"Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia","volume":"4","author":"Walker","year":"2008","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0340","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1037\/0033-295X.104.4.667","article-title":"Schizophrenia: a neural diathesis-stress model","volume":"104","author":"Walker","year":"1997","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0345","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.psyneuen.2004.11.003","article-title":"Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release","volume":"30","author":"Walsh","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0350","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.psyneuen.2005.06.010","article-title":"Altered cortisol awakening response in posttraumatic stress disorder","volume":"31","author":"Wessa","year":"2006","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl. 17","key":"10.1016\/j.psyneuen.2012.12.025_bib0355","first-page":"41","article-title":"Biology of posttraumatic stress disorder","volume":"62","author":"Yehuda","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.12.025_bib0360","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.npp.1300756","article-title":"Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics","volume":"30","author":"Zhang","year":"2005","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:41:34Z","timestamp":1759682494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453013000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0306453013000048"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2012.12.025","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the activity of the hypothalamic\u2013pituitary\u2013adrenal axis in first episode psychosis","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2012.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}